|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/21 | |
| A61K 47/48 | |||
| C07K 16/32 | |||
| A61P 35/00 | |||
| C12N 15/62 |
| (11) | Number of the document | 2200634 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08831632.8 |
| Date of filing the European patent application | 2008-09-19 | |
| (97) | Date of publication of the European application | 2010-06-30 |
| (45) | Date of publication and mention of the grant of the patent | 2015-02-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/077074 |
| Date | 2008-09-19 |
| (87) | Number | WO 2009/039409 |
| Date | 2009-03-26 |
| (30) | Number | Date | Country code |
| 994717 P | 2007-09-21 | US |
| (72) |
MORRISON, Sherie, L., US
HUANG, Tzu-Hsuan, US
XUAN, Caiyun, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (54) | TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES |
| TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES |